TABLE 1 MAJOR HEPATITIS A DRUGS 15
TABLE 2 MAJOR HEPATTIS B DRUGS 16
TABLE 3 MAJOR HEPATITIS C DRUGS 18
TABLE 4 DISEASE TRANSMISSIONS OF DIFFERENT TYPES OF HEPATITIS 19
TABLE 5 GLOBAL HEPATITIS DRUGS MARKET REVENUE BY TYPE' 2016-2023 ($BILLION) 33
TABLE 6 TRENDING HEPATITIS DRUGS' 2014-2016 ($MILLION) 36
TABLE 7 MERCK & CO. INC.: RECENT DEVELOPMENTS 53
TABLE 8 HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 58
TABLE 9 GILEAD SCIENCES: KEY MEDICINES/PRODUCTS 62
TABLE 10 GILEAD SCIENCES: PIPELINE PRODUCTS 63
TABLE 11 GILEAD SCIENCES: RECENT DEVELOPMENTS 65
TABLE 12 NOVARTIS AG: RECENT DEVELOPMENTS 69
TABLE 13 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 75
TABLE 14 VERTEX PHARMACEUTICALS INC.: RECENT DEVELOPMENTS 79
TABLE 15 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 82
TABLE 16 MERGER & ACQUISITION' 2014-2015 85

LIST OF FIGURE

CHART 1 PEST ANALYSIS OF HEPATITIS DRUGS MARKET 11
CHART 2 RESEARCH METHODOLOGY OF GLOBAL HEPATITIS DRUGS MARKET 13
CHART 3 GLOBAL HEPATITIS DRUGS MARKET REVENUE' 2016-2023 ($BILLION) 14
CHART 4 PORTERS 5 FORCES ON GLOBAL HEPATITS DRUGS MARKET 22
CHART 5 EVOLUTION OF HEPATITIS DRUGS 23
CHART 6 REGIMEN ROADMAP OF HEPATITIS C 24
CHART 7 MARKET DYNAMICS - DRIVERS' RESTRAINTS & OPPORTUNITIES 25
CHART 8 DRO - IMPACT ANALYSIS OF HEPATITIS DRUGS MARKET 29
CHART 9 TECHNOLOGY ROADMAP FOR HEPATITIS DRUGS MARKET 31
CHART 10 HEPATITIS DRUGS MARKET BY TYPES 32
CHART 11 GLOBAL HEPATITIS DRUGS MARKET SHARE BY TYPES 2016 32
CHART 12 GLOBAL HEPATITIS DRUGS MARKET REVENUE IN HEPATITIS A SEGMENT' 2016-2023 ($BILLION) 33
CHART 13 GLOBAL HEPATITIS DRUGS MARKET REVENUE IN HEPATITIS B SEGMENT' 2016-2023 ($BILLION) 34
CHART 14 GLOBAL HEPATITIS DRUGS MARKET REVENUE IN HEPATITIS C SEGMENT' 2016-2023 ($BILLION) 35
CHART 15 GEOGRAPHIC REVENUE IN 2015 (%) 42
CHART 16 MERCK & CO. INC.: OVERVIEW SNAPSHOT 50
CHART 17 MERCK & CO. INC.: BUSINESS UNITS 51
CHART 18 GE: GEOGRAPHIC REVENUE 52
CHART 19 MERCK & CO. INC.: SWOT ANALYSIS 54
CHART 20 HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 56
CHART 21 HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 57
CHART 22 HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 58
CHART 23 HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 60
CHART 24 GILEAD SCIENCES: OVERVIEW SNAPSHOT 62
CHART 25 GILEAD SCIENCES: BUSINESS UNITS 63
CHART 26 GILEAD SCIENCES: GEOGRAPHIC REVENUE 65
CHART 27 GILEAD SCIENCES: SWOT ANALYSIS 66
CHART 28 NOVARTIS AG: OVERVIEW SNAPSHOT 67
CHART 29 NOVARTIS AG: BUSINESS UNITS 67
CHART 30 NOVARTIS AG: GEOGRAPHIC REVENUE 69
CHART 31 NOVARTIS AG: SWOT ANALYSIS 71
CHART 32 GLAXOSMITHKLINE PLC: OVERVIEW SNAPSHOT 72
CHART 33 GLAXOSMITHKLINE PLC: BUSINESS UNITS 73
CHART 34 GLAXOSMITHKLINE PLC: GEOGRAPHIC REVENUE 75
CHART 35 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 76
CHART 36 VERTEX PHARMACEUTICALS INC.: OVERVIEW SNAPSHOT 79
CHART 37 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 81

?